Buscar
01/09/2023
Indications and histology of 489 orchiectomies analyzed by patient age.
Fontanet S, Huguet J, Gaya JM, Territo A, Gallioli A, Aumatell J, Algaba F, Palou J, Breda A. Indications and histology of 489 orchiectomies analyzed by patient age.. Actas Urologicas Espanolas. 2023; 47(7)DOI:10.1016/j.acuroe.2022.11.004. PMID:36427799. IF:(Q/D).
01/09/2023
Radiation exposure during different percutaneous renal puncture techniques: A YAU endourology & urolithiasis
Sener, TE, Tanidir, Y, Ketenci, S, Kutukoglu, U, Dorucu, D, Cayir, H, Pietropaolo, A, Emiliani, E, Somani, B. Radiation exposure during different percutaneous renal puncture techniques: A YAU endourology & urolithiasis. Investigative and Clinical Urology. 2023; 64(5)DOI:10.4111/icu.20220395. PMID:37668203. IF:2.500(Q2/4D).
01/01/2023
Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial
van Straten C.G.J.I., Caris C., Grimm M.-O., Colombel M., Muilwijk T., Martínez-Piñeiro L., Babjuk M.M., Türkeri L.N., Palou J., Patel A., Bjartell A.S., Witjes W.P.J., van der Heijden A.G., Kiemeney L.A.L.M.. Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial. European Urology Open Science. 2023; 56DOI:10.1016/j.euros.2023.08.004. PMID:37822514. IF:3.200(Q1/2D).
01/01/2023
New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer
Asimakopoulos A.D., Kochergin M., Colalillo G., Fahmy O., Hassan F., Renninger M., Gallioli A., Gavrilov P., Gakis G.. New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer. Bladder Cancer. 2023; 9(3)DOI:10.3233/BLC-230043. PMID:. IF:1.000(Q4/8D).